Company Profile
Inventera is a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI.
The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.